Quick answer
This page lists 139 chemotherapy doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Chemotherapy doctors in India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
Chemotherapy doctors
FeaturedDr. Rahul Bhargava
MBBS, MD (General Medicine), DM (Clinical Hematology), Advanced Fellowship in Unrelated and Haploidentical Transplant
Principal Director & Chief – Hematology · Specialty: Hematologist & BMT Specialist
Fortis Memorial Research Institute Gurgaon, India20+ Years experience
Why consider this doctor?
- 20+ years of experience in Hematologist & BMT Specialist
- Principal Director – Hemato-Oncology, Fortis Memorial Research Institute, Gurugram (2017 – Present)
- Head of Hematology and BMT, Artemis Hospital, Gurugram (2013 – 2016)
Expertise & Procedures
- Autologous Bone Marrow Transplant
- Allogeneic Bone Marrow Transplant
- Haploidentical BMT
- Unrelated Donor BMT
- Peripheral Blood Stem Cell Transplantation
Hematologist & BMT Specialist Experience: 20+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Dr. Vinod Raina
MBBS, MD (Internal Medicine), DM (Medical Oncology), Fellowship, Fellowship
Chairman – Medical Oncology · Specialty: Medical Oncologist
Fortis Memorial Research Institute Gurgaon, India40+ Years experience
Why consider this doctor?
- 40+ years of experience in Medical Oncologist
- Chairman – Medical Oncology, Fortis Memorial Research Institute, Gurugram (Present)
- Professor and Head of Medical Oncology, AIIMS, New Delhi (2001 – 2013)
Expertise & Procedures
- High-Dose Chemotherapy with Stem Cell Rescue
- Autologous Bone Marrow Transplant
- Chemotherapy (Induction, Consolidation, Maintenance)
- Concurrent Chemoradiotherapy
- Palliative Chemotherapy
Medical Oncologist Experience: 40+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Dr. Vinay Samuel Gaikwad
MBBS, MS (General Surgery), FAIS – Fellow of Association of Surgeons of India, FMAS – Fellow of Minimal Access Surgeons, FIAGES – Fellow of Indian Association of Gastro Endoscopic Surgeons, FACS (USA) – Fellow of the American College of Surgeons, Fellowship in GI Oncology, Hepatopancreatobiliary Oncology Training, Peritoneal Surface Oncology Training
Director – Surgical Oncology · Specialty: Surgical Oncologist (GI & HPB)
Fortis Hospital Manesar Gurugram, India24+ Years experience
Why consider this doctor?
- 24+ years of experience in Surgical Oncologist (GI & HPB)
- Director – Surgical Oncology, Fortis Hospital, Manesar, Gurugram (Present)
- Christian Medical College, Ludhiana
Expertise & Procedures
- Robotic GI Cancer Surgery
- HIPEC (Hyperthermic Intraperitoneal Chemotherapy)
- PIPAC (Pressurised Intraperitoneal Aerosolised Chemotherapy)
- Laparoscopic Colorectal Resection
- Laparoscopic & Robotic Liver Resection
Surgical Oncologist (GI & HPB) Experience: 24+ YearsHospital Affiliation: Fortis Hospital ManesarHospital accreditation: NABH, NABL, JCI
Dr. Pooja Babbar
MBBS, MD Radiation Oncology, Senior Residency, DM Medical Oncology – Gold Medalist, European Certification in Medical Oncology (ESMO), Diploma in Medico Legal System, MBA in Hospital Management
Consultant & Unit Head – Medical Oncology · Specialty: Medical Oncologist
Fortis Hospital Manesar Gurugram, India11+ Years experience
Why consider this doctor?
- 11+ years of experience in Medical Oncologist
- Consultant & Unit Head – Medical Oncology, Fortis Hospital, Manesar, Gurugram (Present)
- American Oncology Institute, Gurugram
Expertise & Procedures
- Chemotherapy (Adjuvant, Neoadjuvant, Palliative)
- Immunotherapy (Checkpoint Inhibitors)
- Targeted Therapy (HER2, EGFR, VEGF, CDK4/6 inhibitors)
- Hormonal Therapy (Breast, Prostate cancer)
- Oncological Emergency Management
Medical Oncologist Experience: 11+ YearsHospital Affiliation: Fortis Hospital ManesarHospital accreditation: NABH, NABL, JCI
Dr. Ashok Kumar Vaid
MBBS, MD (General Medicine), DM (Medical Oncology)
Chairman — Medical Oncology, Hematology & Stem Cell Transplant · Specialty: Medical Oncologist & BMT Specialist
Medanta - The Medicity Gurgaon, India44+ Years experience
Why consider this doctor?
- 44+ years of experience in Medical Oncologist & BMT Specialist
- Chairman — Medical Oncology, Hematology & Stem Cell Transplant, Medanta – The Medicity, Gurgaon (Present)
- Pioneered one of the largest stem cell transplant programmes in private-sector north India
Expertise & Procedures
- Allogeneic Stem Cell Transplant
- Autologous Stem Cell Transplant
- Haploidentical Stem Cell Transplant
- Bone Marrow Aspiration & Biopsy
- Chemotherapy Administration
Medical Oncologist & BMT Specialist Experience: 44+ YearsHospital Affiliation: Medanta - The MedicityHospital accreditation: JCI, NABH
Dr. Arun Singh Danewa
MBBS, MD (Pediatrics), Pediatric Oncology Training, Fellowship in Bone Marrow Transplantation
Sr. Consultant — Pediatric Hematology, Oncology & BMT · Specialty: Pediatric Hematologist & BMT Specialist
Artemis Hospital Gurgaon, India10+ Years experience
Why consider this doctor?
- 10+ years of experience in Pediatric Hematologist & BMT Specialist
- Senior Consultant — Pediatric Hematology, Oncology, Bone Marrow Transplant, Artemis Hospital, Gurugram (Present)
- Pediatric Oncology Fellowship, Sir Ganga Ram Hospital, New Delhi
Expertise & Procedures
- Allogeneic Bone Marrow Transplant
- Autologous Bone Marrow Transplant
- Haploidentical Stem Cell Transplant
- Matched Sibling Donor Transplant for Thalassemia
- Bone Marrow Aspiration & Biopsy
Pediatric Hematologist & BMT Specialist Experience: 10+ YearsHospital Affiliation: Artemis HospitalHospital accreditation: JCI, NABH
Dr. Gaurav Dixit
MBBS, MD (General Medicine), DM (Clinical Haematology), Professional Certificate in Multiple Myeloma
Head — Haematology Oncology & Bone Marrow Transplant (Unit II) · Specialty: Hematologist & BMT Specialist
Artemis Hospital Gurgaon, India17+ Years experience
Why consider this doctor?
- 17+ years of experience in Hematologist & BMT Specialist
- Head — Haematology Oncology & Bone Marrow Transplant (Unit II), Artemis Hospital, Gurugram (Present)
- Senior Consultant — Haematology & BMT, Action Cancer Hospital, Delhi (~4 years)
Expertise & Procedures
- Autologous Stem Cell Transplant
- Matched Sibling Allogeneic Stem Cell Transplant
- Haploidentical Stem Cell Transplant
- Matched Unrelated Donor Transplant
- Bone Marrow Aspiration & Biopsy
Hematologist & BMT Specialist Experience: 17+ YearsHospital Affiliation: Artemis HospitalHospital accreditation: JCI, NABH
Dr. Vikas Dua
MBBS, MD (Paediatrics), FNB (Paediatric Hematology Oncology), Fellowship in Paediatric Bone Marrow Transplant, Outreach Programme in Paediatric BMT
Principal Director & Head — Paediatric Haematology, Haemato-Oncology & BMT · Specialty: Pediatric Hematologist & BMT Specialist
Fortis Memorial Research Institute Gurgaon, India20+ Years experience
Why consider this doctor?
- 20+ years of experience in Pediatric Hematologist & BMT Specialist
- Principal Director & Head — Paediatric Haematology, Haemato-Oncology and BMT, Fortis Memorial Research Institute, Gurgaon (Present)
- Senior Consultant — Paediatric Hemato-Oncology and BMT, Artemis Hospital, Gurgaon
Expertise & Procedures
- Allogeneic Bone Marrow Transplant
- Matched Sibling Donor Transplant
- Matched Unrelated Donor Transplant
- Haploidentical Paediatric Stem Cell Transplant
- Autologous Stem Cell Transplant
Pediatric Hematologist & BMT Specialist Experience: 20+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Dr. Imran Khan
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP — Medical Oncology
Consultant — Medical Oncology · Specialty: Medical Oncologist
Fortis Escorts Heart Institute New Delhi, India10+ Years experience
Why consider this doctor?
- 10+ years of experience in Medical Oncologist
- Consultant — Medical Oncology, Fortis Escorts, Okhla Road, New Delhi (Present)
- Associate Consultant — Medical Oncology, Fortis Escorts, Amritsar
Expertise & Procedures
- Chemotherapy Administration
- Targeted Therapy Infusions
- Immunotherapy Infusions
- PICC Line Insertion
- Bone Marrow Aspiration & Biopsy
Medical Oncologist Experience: 10+ YearsHospital Affiliation: Fortis Escorts Heart InstituteHospital accreditation: JCI, NABH
Dr. Huma Noor
MBBS, MD (General Medicine), DM (Medical Oncology), MRCP — Medical Oncology
Consultant — Medical Oncology · Specialty: Medical Oncologist
Fortis Escorts Heart Institute New Delhi, India11+ Years experience
Why consider this doctor?
- 11+ years of experience in Medical Oncologist
- Consultant — Medical Oncology, Fortis Escorts, Okhla Road, New Delhi (Present)
- Consultant — Medical Oncology, Fortis Escorts, Amritsar
Expertise & Procedures
- Chemotherapy Administration
- Immunotherapy Infusions
- Targeted & Hormonal Therapy
- Autologous Stem Cell Transplant
- Allogeneic Stem Cell Transplant (Paediatric & Adult)
Medical Oncologist Experience: 11+ YearsHospital Affiliation: Fortis Escorts Heart InstituteHospital accreditation: JCI, NABH
Hospitals where these doctors practise
🇮🇳 Manesar, Gurgaon, IndiaStarting from$1,000
Fortis Hospital Manesar
Est. 2013
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditationJCI — Joint Commission International accreditation
ChemotherapyCardiac SurgeryOrthopedicsBariatric Surgery
2+
Doctors for Chemotherapy
4.4
74 reviews
350+
Beds
13+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$1,000
Medanta - The Medicity
Est. 2009
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ChemotherapyCardiac SurgeryCardiologyMedical Oncology
15+
Doctors for Chemotherapy
4.9
2150 reviews
1600+
Beds
17+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$1,000
Artemis Hospital
Est. 2007
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ChemotherapyCardiac SurgeryCardiologyMedical Oncology
5+
Doctors for Chemotherapy
4.9
64 reviews
750+
Beds
19+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$1,000
Fortis Memorial Research Institute
Est. 1996
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ChemotherapyCardiac SurgeryCardiologyMedical Oncology
7+
Doctors for Chemotherapy
4.8
1100 reviews
1000+
Beds
30+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$1,000
Fortis Escorts Heart Institute
Est. 1988
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ChemotherapyCardiac SurgeryCardiologyMedical Oncology
4+
Doctors for Chemotherapy
4.5
24 reviews
310+
Beds
38+
Years Since Founded
🇮🇳 Chennai, IndiaStarting from$1,000
Dr. Rela Institute and Medical Centre
Est. 2018
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
ChemotherapyCardiac SurgeryCardiologyMedical Oncology
8+
Doctors for Chemotherapy
4.7
108 reviews
450+
Beds
8+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$1,000
Apollo Hospitals
Est. 1983
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ChemotherapyCardiac SurgeryCardiologyMedical Oncology
14+
Doctors for Chemotherapy
4.9
1240 reviews
1000+
Beds
43+
Years Since Founded
Why consider treatment in India?
Many international patients consider India for prostate & other urological cancers treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
About the Procedure
What is Chemotherapy?
Chemotherapy is a systemic cancer treatment that uses potent drugs to destroy or slow the growth of cancer cells, either as a standalone treatment or combined with surgery and radiation therapy. It is typically administered in cycles over several weeks to months, tailored to the cancer type, stage, and patient's overall health. GAF Healthcare connects international patients with leading Indian oncology centers offering world-class chemotherapy protocols at a fraction of Western costs.
Who may be considered?
Chemotherapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.
How does it work?
Drugs are infused directly into the bloodstream through a vein, cannula, or implanted port, allowing systemic distribution throughout the body.
3 approaches available for this procedure:
Intravenous (IV) Chemotherapy
Most CommonDrugs are infused directly into the bloodstream through a vein, cannula, or implanted port, allowing systemic distribution throughout the body.
Comprehensive Investigations
Estimated cost: $200 - $600
CBC, liver and kidney function tests, tumor markers, CT/PET scan, ECG, echocardiogram (for cardiotoxic drugs), biopsy confirmation report
Treatment / Procedure Estimate
Estimated cost in India: $1,500 - $6,000
Stay in India
Pre-procedure stay (outside hospital): ~2 days
Hospitalisation: ~1 day per cycle (outpatient/day-care)
Recovery period (outside hospital): ~7-14 days between cycles
Total stay: approx 3-6 months (full treatment course)
Usually Included in Hospital Package
- Oncologist consultations
- Chemotherapy drugs (standard protocol)
- Day-care/nursing during infusion
- Pre-cycle blood monitoring
- Anti-nausea/supportive medications
Usually Not Included
- Targeted therapy or immunotherapy add-ons
- PICC line/port implantation surgery
- Hospitalization for complications
- Accommodation between cycles
- Travel and visa costs
Recovery and follow-up
Patients typically experience fatigue, nausea, and lowered immunity between cycles, requiring regular blood monitoring and supportive care; full recovery of energy levels may take several weeks after the final cycle. Long-term follow-up includes periodic scans and blood tests to monitor treatment response.
Risks
Common risks include nausea, hair loss, fatigue, low blood counts, and increased infection risk, while rare but serious risks include organ toxicity (heart, liver, or kidney) and severe allergic reactions. Regular monitoring helps detect and manage side effects early.
Alternatives
Depending on the cancer type and stage, alternatives or complements to chemotherapy may include surgery, radiation therapy, targeted therapy, immunotherapy, or hormone therapy. The best approach is determined by a multidisciplinary tumor board based on the patient's specific diagnosis.
What we need to prepare a formal estimate
Share whatever you have — the care team will confirm the final checklist after reviewing your case.
Reports required
- Histopathology/biopsy report confirming cancer diagnosis
- CT/PET/MRI imaging reports
- Complete blood count (CBC) and metabolic panel
- Liver and kidney function test results
- Tumor marker test results
- ECG/echocardiogram report (if cardiotoxic drugs planned)
- Previous treatment summary (surgery, radiation, prior chemotherapy)
- List of current medications and allergies
Patient information needed
- Type, stage, and grade of cancer
- Age, weight, and general health status
- Comorbidities (diabetes, heart or kidney disease)
- Previous cancer treatments and response
- Current medications and known allergies
- Family history of cancer (if relevant)
- Preferred treatment duration and travel dates
- Availability of a caregiver during treatment
Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.
How this directory is built
Doctors are matched using the specialty, location, condition (Chemotherapy) and procedure (Chemotherapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Chemotherapy in India
What is Prostate & Other Urological Cancers?
Prostate and other urological cancers are malignant tumours that develop in organs of the urinary and male reproductive system — most commonly the prostate gland, but also the bladder, kidneys, and testes. They differ significantly in their rate of growth, risk of spread, and response to treatment, meaning each case requires individual evaluation.
What are the symptoms and health risks of Prostate & Other Urological Cancers?
Symptoms differ by cancer type and stage: prostate cancer may cause difficulty urinating, weak urine flow, blood in urine or semen, or pelvic discomfort, while bladder cancer often presents with painless blood in the urine, and kidney cancer may produce flank pain, a palpable mass, or unexplained weight loss. In early stages, many urological cancers produce no symptoms at all, making incidental detection through screening or imaging particularly important. These symptoms can also be caused by non-cancerous conditions, so their presence alone is not sufficient to establish a diagnosis.
How is Prostate & Other Urological Cancers diagnosed?
Diagnosis typically begins with a detailed clinical history and physical examination — including a digital rectal exam (DRE) for suspected prostate cancer — followed by blood tests such as PSA (prostate-specific antigen) for prostate cancer or urine cytology for bladder cancer. Imaging studies including ultrasound, CT, or MRI are used to assess tumour size, location, and potential spread, and a tissue biopsy is usually required to confirm malignancy and determine the tumour's grade. For prostate cancer, the Gleason score and Grade Group are key grading tools, while bladder and kidney cancers are staged using the TNM (Tumour-Node-Metastasis) system to guide treatment planning.
How is Prostate & Other Urological Cancers treated?
Treatment decisions depend on the cancer type, grade, stage, and the patient's overall health and preferences, and are best made by a multidisciplinary team. Options range from active surveillance for low-risk, slow-growing prostate cancer, to medical treatments such as hormone therapy, chemotherapy, and targeted therapy, as well as surgical interventions (such as radical prostatectomy, nephrectomy, or cystectomy) and radiation therapy. No single approach is universally appropriate, and a qualified oncologist will weigh the potential benefits and risks in the context of each individual's clinical profile.
Can Prostate & Other Urological Cancers be treated without a procedure?
Meaningful non-surgical pathways exist for many urological cancers: active surveillance (regular PSA testing, imaging, and repeat biopsy) is a recognised standard of care for carefully selected low-risk prostate cancers, while hormone therapy (androgen deprivation therapy), chemotherapy, and targeted or immunotherapy agents are established treatments for locally advanced or metastatic disease. Radiation therapy — delivered externally or via brachytherapy — is another non-surgical option for eligible patients. The appropriateness of each approach depends on an individualised assessment by a treating specialist.
When is Chemotherapy considered for Prostate & Other Urological Cancers?
Chemotherapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Prostate & Other Urological Cancers?
Urological cancers are primarily evaluated and managed by a medical oncologist with experience in genitourinary cancers, often working alongside a urologist for surgical considerations and a radiation oncologist when radiotherapy is part of the plan. In comprehensive centres, a multidisciplinary tumour board — which may also include pathologists, radiologists, and specialist nurses — reviews complex cases to ensure coordinated, evidence-based care.
How do I choose a doctor for Prostate & Other Urological Cancers?
When selecting a specialist, it is worth asking about their specific experience managing your cancer type (e.g. prostate, bladder, or kidney), whether the centre holds regular multidisciplinary tumour board meetings, and what follow-up and survivorship support are available after treatment. Access to advanced diagnostic imaging, clinical trials, and a dedicated patient navigator can also make a meaningful difference in the continuity and quality of your care.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.